13.705 USD
+0.23 (+1.74%)
We assign a fundamental rating of 3 out of 10 to DXR. DXR was compared to 186 industry peers in the Health Care Equipment & Supplies industry. DXR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. DXR is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- DXR had positive earnings in the past year.
- In the past year DXR had a positive cash flow from operations.
- Of the past 5 years DXR 4 years were profitable.
- DXR had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
- The Return On Assets of DXR (5.01%) is better than 81.18% of its industry peers.
- DXR's Return On Equity of 5.05% is fine compared to the rest of the industry. DXR outperforms 78.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.01% | ||
| ROE | 5.05% | ||
| ROIC | N/A |
ROA(3y)6.45%
ROA(5y)5.61%
ROE(3y)6.73%
ROE(5y)6.34%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With an excellent Profit Margin value of 2707.08%, DXR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
- DXR's Profit Margin has declined in the last couple of years.
- DXR does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 2707.08% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-35.84%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The number of shares outstanding for DXR has been increased compared to 1 year ago.
- The number of shares outstanding for DXR has been increased compared to 5 years ago.
- The debt/assets ratio for DXR has been reduced compared to a year ago.
2.2 Solvency
- DXR has an Altman-Z score of 151.17. This indicates that DXR is financially healthy and has little risk of bankruptcy at the moment.
- With an excellent Altman-Z score value of 151.17, DXR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
- The Debt to FCF ratio of DXR is 0.19, which is an excellent value as it means it would take DXR, only 0.19 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of DXR (0.19) is better than 92.47% of its industry peers.
- DXR has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
- DXR has a Debt to Equity ratio of 0.01. This is in the better half of the industry: DXR outperforms 72.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.19 | ||
| Altman-Z | 151.17 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- DXR has a Current Ratio of 0.04. This is a bad value and indicates that DXR is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Current ratio of DXR (0.04) is worse than 96.24% of its industry peers.
- A Quick Ratio of 0.04 indicates that DXR may have some problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 0.04, DXR is doing worse than 96.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.04 | ||
| Quick Ratio | 0.04 |
3. Growth
3.1 Past
- DXR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.53%, which is quite impressive.
- DXR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -54.84% yearly.
- DXR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -56.97%.
- The Revenue for DXR have been decreasing by -20.63% on average. This is quite bad
EPS 1Y (TTM)22.53%
EPS 3Y-54.84%
EPS 5YN/A
EPS Q2Q%77.93%
Revenue 1Y (TTM)-56.97%
Revenue growth 3Y-24.67%
Revenue growth 5Y-20.63%
Sales Q2Q%-74.37%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- DXR is valuated quite expensively with a Price/Earnings ratio of 33.43.
- Compared to the rest of the industry, the Price/Earnings ratio of DXR indicates a somewhat cheap valuation: DXR is cheaper than 73.12% of the companies listed in the same industry.
- The average S&P500 Price/Earnings ratio is at 27.32. DXR is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.43 | ||
| Fwd PE | N/A |
4.2 Price Multiples
- DXR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DXR is cheaper than 73.66% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 49.22 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- DXR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:DXR (1/21/2026, 8:11:31 PM)
13.705
+0.23 (+1.74%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)03-04 2026-03-04
Inst Owners1.73%
Inst Owner Change0%
Ins Owners5.89%
Ins Owner Change0.41%
Market Cap68.25M
Revenue(TTM)66.40K
Net Income(TTM)1.80M
Analysts80
Price Target23.97 (74.9%)
Short Float %0.38%
Short Ratio1.77
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.43 | ||
| Fwd PE | N/A | ||
| P/S | 1027.88 | ||
| P/FCF | 49.22 | ||
| P/OCF | 49.22 | ||
| P/B | 1.92 | ||
| P/tB | 1.92 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.41
EY2.99%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.28
FCFY2.03%
OCF(TTM)0.28
OCFY2.03%
SpS0.01
BVpS7.15
TBVpS7.15
PEG (NY)N/A
PEG (5Y)N/A
Graham Number8.12
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.01% | ||
| ROE | 5.05% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 2707.08% | ||
| GM | N/A | ||
| FCFM | 2088.4% |
ROA(3y)6.45%
ROA(5y)5.61%
ROE(3y)6.73%
ROE(5y)6.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-35.84%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.19 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | 77.15% | ||
| Current Ratio | 0.04 | ||
| Quick Ratio | 0.04 | ||
| Altman-Z | 151.17 |
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.53%
EPS 3Y-54.84%
EPS 5YN/A
EPS Q2Q%77.93%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-56.97%
Revenue growth 3Y-24.67%
Revenue growth 5Y-20.63%
Sales Q2Q%-74.37%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-83.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y144.02%
FCF growth 3YN/A
FCF growth 5Y-61.68%
OCF growth 1Y144.02%
OCF growth 3YN/A
OCF growth 5Y-61.68%
DAXOR CORP / DXR FAQ
Can you provide the ChartMill fundamental rating for DAXOR CORP?
ChartMill assigns a fundamental rating of 3 / 10 to DXR.
Can you provide the valuation status for DAXOR CORP?
ChartMill assigns a valuation rating of 2 / 10 to DAXOR CORP (DXR). This can be considered as Overvalued.
Can you provide the profitability details for DAXOR CORP?
DAXOR CORP (DXR) has a profitability rating of 3 / 10.
How financially healthy is DAXOR CORP?
The financial health rating of DAXOR CORP (DXR) is 5 / 10.
Can you provide the dividend sustainability for DXR stock?
The dividend rating of DAXOR CORP (DXR) is 0 / 10 and the dividend payout ratio is 0%.